In Defense of Evidence-based Medicine for the Treatment of COVID-19 Acute Respiratory Distress Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Defense of Evidence-based Medicine for the Treatment of COVID-19 Acute Respiratory Distress Syndrome

Published:2020-07 Issue:7 Volume:17 Page:787-789
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Rice Todd W.¹^ORCID,Janz David R.²³

Affiliation:

1. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. University Medical Center, New Orleans, Louisiana; and

3. Section of Pulmonary and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference18 articles.

1. Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-α Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock

2. Randomized Clinical Trial of Activated Protein C for the Treatment of Acute Lung Injury

3. Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS);International Journal of Pharmaceutics;2024-05

2. Corticosteroid Uptake For COVID-19 after Publication of RECOVERY: A Difference in Difference Model;Annals of the American Thoracic Society;2023-03

3. The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort;Frontiers in Medicine;2022-08-31

4. A novel intubation prediction model for patients hospitalized with COVID-19: the OTO-COVID-19 scoring model;Current Medical Research and Opinion;2022-07-10

5. Hospital Variation in Management and Outcomes of Acute Respiratory Distress Syndrome Due to COVID-19;Critical Care Explorations;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3